FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1873011119> ?p ?o ?g. }

• W1873011119 abstract "Modified response evaluation criteria in solid tumors (mRECIST) and RECIST are used to assess the effect of treatment with targeted agents for hepatocellular carcinoma (HCC). The aim of this study was to determine which set of criteria is superior in patients with advanced HCC treated with sorafenib.A multicenter retrospective study to assess the tumor response and patient prognosis of 191 patients with HCC who had been treated with sorafenib from May 2009 through December 2011. We analyzed tumor responses as shown by contrast-enhanced computed tomography scan images according to RECIST 1.1 and mRECIST and compared the findings.The median duration of follow-up was 9.7 months and median overall survival was 10.8 months. Twenty-five patients (13.1 %) were assessed as responders by mRECIST and 15 (7.8 %) by RECIST 1.1. There was a significant difference in overall survival (OS) between responders and non-responders according to mRECIST (P = 0.0117), but no significant difference in OS between responders and non-responders according to RECIST 1.1 (P = 0.0722). Sixteen patients (8.4 %) had no measurable enhanced target lesions that could be assessed as required by mRECIST; however, these patients could be assessed by RECIST 1.1. According to RECIST 1.1, eight of them had stable disease (SD) and eight had progressive disease (PD). There was a significant difference in OS between these SD and PD patients (P = 0.0312).Patients treated with sorafenib for HCC should be evaluated by mRECIST; RECIST 1.1 is preferable only for assessment of patients with lesions that are non-measurable according to mRESIST." @default.
• W1873011119 created "2016-06-24" @default.
• W1873011119 creator A5005845869 @default.
• W1873011119 creator A5008862276 @default.
• W1873011119 creator A5010021470 @default.
• W1873011119 creator A5018258244 @default.
• W1873011119 creator A5030492549 @default.
• W1873011119 creator A5034675205 @default.
• W1873011119 creator A5042231482 @default.
• W1873011119 creator A5045455689 @default.
• W1873011119 creator A5049478957 @default.
• W1873011119 creator A5056673407 @default.
• W1873011119 creator A5068425977 @default.
• W1873011119 creator A5083083283 @default.
• W1873011119 date "2015-10-26" @default.
• W1873011119 modified "2023-10-06" @default.
• W1873011119 title "Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma" @default.
• W1873011119 cites W1488835948 @default.
• W1873011119 cites W1584669207 @default.
• W1873011119 cites W1971837077 @default.
• W1873011119 cites W1988508343 @default.
• W1873011119 cites W1990623643 @default.
• W1873011119 cites W1994193851 @default.
• W1873011119 cites W2002279402 @default.
• W1873011119 cites W2013953113 @default.
• W1873011119 cites W2019607817 @default.
• W1873011119 cites W2020215421 @default.
• W1873011119 cites W2024029636 @default.
• W1873011119 cites W2040970018 @default.
• W1873011119 cites W2056227962 @default.
• W1873011119 cites W2057857957 @default.
• W1873011119 cites W2060183623 @default.
• W1873011119 cites W2079586464 @default.
• W1873011119 cites W2104630532 @default.
• W1873011119 cites W2107464631 @default.
• W1873011119 cites W2108549165 @default.
• W1873011119 cites W2115113482 @default.
• W1873011119 cites W2120647133 @default.
• W1873011119 cites W2123534406 @default.
• W1873011119 cites W2125879455 @default.
• W1873011119 cites W2139248078 @default.
• W1873011119 cites W2142020092 @default.
• W1873011119 cites W2153935627 @default.
• W1873011119 cites W2163403599 @default.
• W1873011119 cites W2163890909 @default.
• W1873011119 cites W2418766581 @default.
• W1873011119 cites W4245784696 @default.
• W1873011119 doi "https://doi.org/10.1186/s13104-015-1565-2" @default.
• W1873011119 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4624170" @default.
• W1873011119 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26502722" @default.
• W1873011119 hasPublicationYear "2015" @default.
• W1873011119 type Work @default.
• W1873011119 sameAs 1873011119 @default.
• W1873011119 citedByCount "28" @default.
• W1873011119 countsByYear W18730111192016 @default.
• W1873011119 countsByYear W18730111192017 @default.
• W1873011119 countsByYear W18730111192018 @default.
• W1873011119 countsByYear W18730111192019 @default.
• W1873011119 countsByYear W18730111192020 @default.
• W1873011119 countsByYear W18730111192021 @default.
• W1873011119 countsByYear W18730111192022 @default.
• W1873011119 countsByYear W18730111192023 @default.
• W1873011119 crossrefType "journal-article" @default.
• W1873011119 hasAuthorship W1873011119A5005845869 @default.
• W1873011119 hasAuthorship W1873011119A5008862276 @default.
• W1873011119 hasAuthorship W1873011119A5010021470 @default.
• W1873011119 hasAuthorship W1873011119A5018258244 @default.
• W1873011119 hasAuthorship W1873011119A5030492549 @default.
• W1873011119 hasAuthorship W1873011119A5034675205 @default.
• W1873011119 hasAuthorship W1873011119A5042231482 @default.
• W1873011119 hasAuthorship W1873011119A5045455689 @default.
• W1873011119 hasAuthorship W1873011119A5049478957 @default.
• W1873011119 hasAuthorship W1873011119A5056673407 @default.
• W1873011119 hasAuthorship W1873011119A5068425977 @default.
• W1873011119 hasAuthorship W1873011119A5083083283 @default.
• W1873011119 hasBestOaLocation W18730111191 @default.
• W1873011119 hasConcept C126322002 @default.
• W1873011119 hasConcept C126838900 @default.
• W1873011119 hasConcept C143998085 @default.
• W1873011119 hasConcept C167135981 @default.
• W1873011119 hasConcept C2778019345 @default.
• W1873011119 hasConcept C2778695046 @default.
• W1873011119 hasConcept C2778822529 @default.
• W1873011119 hasConcept C2779134260 @default.
• W1873011119 hasConcept C2779984678 @default.
• W1873011119 hasConcept C2989005 @default.
• W1873011119 hasConcept C71924100 @default.
• W1873011119 hasConceptScore W1873011119C126322002 @default.
• W1873011119 hasConceptScore W1873011119C126838900 @default.
• W1873011119 hasConceptScore W1873011119C143998085 @default.
• W1873011119 hasConceptScore W1873011119C167135981 @default.
• W1873011119 hasConceptScore W1873011119C2778019345 @default.
• W1873011119 hasConceptScore W1873011119C2778695046 @default.
• W1873011119 hasConceptScore W1873011119C2778822529 @default.
• W1873011119 hasConceptScore W1873011119C2779134260 @default.
• W1873011119 hasConceptScore W1873011119C2779984678 @default.
• W1873011119 hasConceptScore W1873011119C2989005 @default.
• W1873011119 hasConceptScore W1873011119C71924100 @default.
• W1873011119 hasIssue "1" @default.
• W1873011119 hasLocation W18730111191 @default.

• next